Details

Vrednotenje učinkovitosti zdravljenja bolnic s HER2-pozitivnim rakom dojke s trastuzumabom : diplomska naloga
ID Musizza, Teja (Author), ID Mrhar, Aleš (Mentor) More about this mentor... This link opens in a new window, ID Sonc, Monika (Comentor)

URLURL - Presentation file, Visit http://www.ffa.uni-lj.si/fileadmin/datoteke/Knjiznica/diplome/2010/Musizza_Teja_dipl_nal_2010.pdf This link opens in a new window

Language:Slovenian
Keywords:HER2-receptor, rak dojk, trastuzumab, farmakokinetika, interkacije, neželeni učinki
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:FFA - Faculty of Pharmacy
Place of publishing:Ljubljana
Publisher:[T. Musizza]
Year:2010
Number of pages:VI, 70 f.
PID:20.500.12556/RUL-71016 This link opens in a new window
UDC:615.015
COBISS.SI-ID:2801521 This link opens in a new window
Publication date in RUL:10.07.2015
Views:2084
Downloads:1095
Metadata:XML DC-XML DC-RDF
:
MUSIZZA, Teja, 2010, Vrednotenje učinkovitosti zdravljenja bolnic s HER2-pozitivnim rakom dojke s trastuzumabom : diplomska naloga [online]. Bachelor’s thesis. Ljubljana : T. Musizza. [Accessed 9 April 2025]. Retrieved from: http://www.ffa.uni-lj.si/fileadmin/datoteke/Knjiznica/diplome/2010/Musizza_Teja_dipl_nal_2010.pdf
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Evaluation of efficacy of treatment with trastuzumab in patients with HER2 positive breast cancer

Similar documents

Similar works from RUL:
  1. Klinični pomen določanja tumorskega označevalca NMP22 pri raku sečnega mehurja
  2. Determination of tumour marker HE4 in ovarian and endometrical cancer
  3. Clinical significance of tumor markers mRNAs in urine of bladder cancer patients
  4. ǂThe ǂclinical value of tumour markers CEA and CA 19-9 in pancreatic cancer
  5. Diagnostic value of prostate specific proantigen in patients with prostate cancer
Similar works from other Slovenian collections:
  1. Rak sečnega mehurja - obsevalno zdravljenje
  2. Rak sečnega mehurja
  3. Rak sečnega mehurja
  4. Rak sečnega mehurja
  5. Kirurško zdravljenje raka sečnega mehurja

Back